FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Agios Seeks Expanded Use for Pyrukynd

[ Price : $8.95]

Agios files a supplemental NDA for an expanded indication for its Pyrukynd (mitapivat) for treating adult patients with alpha- or ...

FDA Clears Prostate Tissue Ablator

[ Price : $8.95]

FDA clears an AngioDynamics 510(k) for the NanoKnife System for prostate tissue ablation.

AbbVie Reports Positive Parkinsons Trial Data

[ Price : $8.95]

AbbVie announces positive topline results from its pivotal Phase 3 TEMPO-2 trial evaluating tavapadon as an early Parkinson's dise...

Chimerix Plans Accelerated Approval NDA for Gliomas Drug

[ Price : $8.95]

Chimerix plans to submit an NDA before the end of the year seeking accelerated approval for dordaviprone for treating recurrent H3...

Fresenius Hit With 11-Item FDA-483

[ Price : $8.95]

FDA releases an 11-item Form FDA-483 from a 10/2023 Fresenius Kabi Oncology inspection at the companys Pradesh, India manufacturin...

e-Submission Guide for BIMO Inspection Planning

[ Price : $8.95]

FDA posts a final guidance entitled Standardized Format for Electronic Submission of NDA and BLA Content for the Planning of Biore...

Panel to Discuss Opioid Abuse Studies

[ Price : $8.95]

Federal Register notice: FDA announces a 2/5 joint meeting of its Drug Safety and Risk Management Advisory Committee and Anestheti...

Drug/Biologic Accelerated Approval Draft Guide

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Expedited Program for Serious Conditions Accelerated Appro...

GE Healthcare Recalls Newborn Incubators

[ Price : $8.95]

GE Healthcare has recalled its Giraffe Omnibed Carestation and Incubator Carestation due to the potential for excessive formaldehy...

Groups Urge Rare Disease Voucher Reauthorization

[ Price : $8.95]

A letter from dozens of patient advocacy groups urges congressional leaders to pass the Creating Hope Reauthorization Act, which w...